-
Pfizer Steps Further In The Door For Gene Therapies
Post on 3/25/19
-
Better Buy: Verizon vs. Johnson & Johnson
Post on 3/25/19
-
Thermo Fisher Scientific Instruments Recognized by SelectScience
Post on 3/21/19
-
Lannett Purchases $24 Million Of Term Loans In Open Market Transactions
Post on 3/21/19
-
Celgene Presents An Attractive Short-Term Investment Opportunity In March 2019
Post on 3/21/19
-
LifeCare Hospitals of Chester County Earns Respiratory Failure Certification
Post on 3/20/19
-
Emisphere Development Update
Post on 3/20/19
-
Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022
Post on 3/20/19
-
Pfizer To Acquire Vivet Therapeutics
Post on 3/20/19
-
Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
Post on 3/20/19
-
Ariel Precision Medicine Named Life Sciences PA Emerging Company of the Year
Post on 3/19/19
-
Onconova Therapeutics to Provide Corporate Update
Post on 3/19/19
-
New Study: Reusable Bronchoscopes Cost More Than Sterile Single-use Bronchoscopes
Post on 3/19/19
-
MHA Recognized as a Best Place to Work in NJ
Post on 3/19/19
-
LLR Partners Invests in CareATC
Post on 3/19/19
-
Cognizant Modernizes EmblemHealth Legacy Systems
Post on 3/18/19
-
Pfizer Venture Investments Joins $63M Series B For Imara
Post on 3/18/19
-
For Bristol-Myers Squibb's Sake, Celgene Merger Should Be Voted Down
Post on 3/18/19
-
Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
Post on 3/18/19
-
Matinas BioPharma Prices Public Offering of Common Stock
Post on 3/17/19
-
Outlook Therapeutics Announces Reverse Stock Split
Post on 3/17/19
-
Matinas BioPharma Announces Proposed Public Offering of Common Stock
Post on 3/14/19
-
Bellerophon Provides Business Update
Post on 3/14/19
-
PharmMD Changes Company Name to AdhereHealth
Post on 3/14/19
-
Onkos Surgical Announces Partnership with Promimic AB
Post on 3/14/19